KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Enterprise Value: 2018-2025

Historic Enterprise Value for BioNTech SE (BNTX) over the last 7 years, with Sep 2025 value amounting to $6.7 billion.

  • BioNTech SE's Enterprise Value fell 32.00% to $6.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.9 billion, marking a year-over-year increase of 3.72%. This contributed to the annual value of $9.4 billion for FY2024, which is 28.84% up from last year.
  • As of Q3 2025, BioNTech SE's Enterprise Value stood at $6.7 billion, which was down 30.71% from $9.7 billion recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Enterprise Value peaked at $66.2 billion during Q3 2021, and registered a low of $478.1 million during Q2 2024.
  • Its 3-year average for Enterprise Value is $8.2 billion, with a median of $8.9 billion in 2023.
  • In the last 5 years, BioNTech SE's Enterprise Value plummeted by 94.73% in 2024 and then skyrocketed by 1,929.98% in 2025.
  • BioNTech SE's Enterprise Value (Quarterly) stood at $46.5 billion in 2021, then tumbled by 52.31% to $22.2 billion in 2022, then plummeted by 67.13% to $7.3 billion in 2023, then grew by 28.84% to $9.4 billion in 2024, then plummeted by 32.00% to $6.7 billion in 2025.
  • Its last three reported values are $6.7 billion in Q3 2025, $9.7 billion for Q2 2025, and $7.0 billion during Q1 2025.